KAKEHASHI is a Healthtech company based in Minato-ku, Tokyo, Japan. It has raised $140M in total funding. Latest round: Series D. Backed by Goldman Sachs.
KAKEHASHI funding overview
KAKEHASHI is a Healthtech company based in Minato-ku, Tokyo, Japan. KAKEHASHI has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in June 2025. The round record for KAKEHASHI runs through 2025; nothing later has been disclosed. Investors on record include Goldman Sachs.
KAKEHASHI at a glance
Total raised
$140M
Latest round
Series D
Latest round date
June 2025
Industry
Healthtech
Headquarters
Minato-ku, Tokyo, Japan
Notable investors
Goldman Sachs
Frequently asked about KAKEHASHI funding
How much has KAKEHASHI raised?
KAKEHASHI has raised $140M in total disclosed funding across the rounds on record.
Who has invested in KAKEHASHI?
Goldman Sachs are named among the investors backing KAKEHASHI.
What was the latest KAKEHASHI funding round?
The most recent disclosed round is a Series D, announced in June 2025.
Where is KAKEHASHI based?
KAKEHASHI is based in Minato-ku, Tokyo, Japan.
What sector does KAKEHASHI operate in?
KAKEHASHI is tracked under Healthtech from Minato-ku, Tokyo, Japan, with $140M in disclosed funding.
When did KAKEHASHI last raise?
The last disclosed KAKEHASHI round closed in June 2025 at Series D.
Every KAKEHASHI figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in Minato-ku at a similar stage.
